Article
Mutation Severity of FBXO43 Determines Spermatogenic Outcome and Informs Precision ART Strategies.
Human mutation - 1 Jan 2026
Xiao Yanqin, He Yutong, Meng Lanlan, Zhang Huan, Tu Chaofeng, Tan Yueqiu, Hu Liang
Abstract excerpt
Objective: FBXO43 is a known inhibitor of the anaphase-promoting complex/cyclosome (APC/C), a key E3 ubiquitin ligase that controls meiotic cell cycle progression. However, how different FBXO43 mutations affect APC/C inhibition and lead to divergent clinical phenotypes remains unclear. This study is aimed at clarifying how different FBXO43 mutations produce divergent clinical phenotypes in male infertility and to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
